Last edition
News about "Mirabegron Extended-Release Tablets"
Lupin Unveils Mirabegron Extended-Release Tablets in US
Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq Extended-Release Tablets, 50 mg of Astellas Pharma Global Development, Inc.
Mirabegron Extended-Release Tablets | 06/09/2024 | By Aishwarya | 137
Lupin Launches Mirabegron Extended-Release Tablets in US
Lupin Ltd. has developed Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received approval from the United States Food and Drug Administration (US FDA).
Mirabegron Extended-Release Tablets | 22/04/2024 | By Aishwarya | 217
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy